Phase IIa
Positive Phase IIa results for Cereno, clear path forward
Cereno Scientific recently announced positive topline results from the Phase IIa study of CS1 in pulmonary arterial hypertension. The results show that the candidate...
Annexin Pharmaceuticals: Can ANXV replace anti-VEGFs?
Annexin Pharmaceuticals is developing the drug candidate ANXV in the eye disease retinal...
Intervju
Video
Follicum reaches milestone in hair study
Yesterday it was announced that Follicum has now recruited over...
New patent announcement rounds off eventful six months for Follicum
During the first half of 2020, Follicum has begun...
Two capital rounds provide new fuel for Follicum's exit strategy
On July 4, Follicum's two parallel issues will close...
Follicum's two projects attract capital from funds and foundations
Follicum's goal is to develop its two drug candidates...